In Washington: The Trump administration will no longer hold back the second dose of a coronavirus vaccine in order to speed up inoculations. The changes are a departure from current policy and align with a plan unveiled by...more
Dr. Harkonen was the CEO of InterMune, Inc, a pharmaceutical company that developed, marketed and sold drugs for lung and liver diseases, including Actimmune. In 2002, the FDA had approved Actimmune to treat only two...more